NCT00300911View on ClinicalTrials.gov

Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone(drug), cardiac adverse effects

Trial Locations (1)

06490

Baskent University Ankara Hospital, Ankara

All Listed Sponsors
lead

Baskent University

OTHER

NCT00300911 - Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction | Biotech Hunter | Biotech Hunter